Literature DB >> 15784253

The nuclear receptor coactivator PGC-1alpha exhibits modes of interaction with the estrogen receptor distinct from those of SRC-1.

Anne Bourdoncle1, Gilles Labesse, Raphaël Margueron, Audrey Castet, Vincent Cavaillès, Catherine A Royer.   

Abstract

Estrogen receptor (ER) function is mediated by multi-domain co-regulator proteins. A fluorescently labelled fragment of the human PGC-1alpha co-regulator (residues 91-408) bearing the two motifs most strongly implicated in interactions with nuclear receptors (NR box2 and NR box3), was used to characterize in vitro binding of PGC-1alpha to ER. Anisotropy measurements revealed that the affinity of this PGC-1alpha fragment for human ERalpha and beta was fairly strong in the presence of estradiol (approximately 5 nM), and that unlike a similar fragment of SRC-1 (570-780), PGC-191-408 exhibited ligand-independent interactions with ER, particularly with ERbeta (Kd approximately 30 nM). Competition experiments of the complex between ERalpha and fluorescently labelled PGC-1 91-408 with unlabelled SRC-1 570-780 showed that PGC-1 91-408 was an efficient competitor of SRC-1 570-780, while the inverse was not true, underscoring their distinct modes of binding. The anisotropy data provide strong evidence for a ternary complex between ERalpha, SRC-1 570-780 and PGC-1 91-408. GST-pull-down experiments with deletion mutants of ERalpha revealed that the constitutive binding of PGC-1 91-408 requires the presence of the linker domain between the DNA binding and ligand binding domains (DBD and LBD). Homology modeling studies of the different regions of full length PGC-1alpha confirmed the lack of compact tertiary structure of the N-terminal region bearing the NR box motifs, and suggested a slightly different mode of interaction compared to the NR box motifs of SRC-1. They also provided reasonable structural models for the coiled-coil dimerization motif at residues 633-675, as well as the C-terminal putative RNA binding domain, raising important questions concerning the stoichiometry of its complex with the nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784253     DOI: 10.1016/j.jmb.2005.01.048

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Determining the stoichiometry of protein heterocomplexes in living cells with fluorescence fluctuation spectroscopy.

Authors:  Yan Chen; Joachim D Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-16       Impact factor: 11.205

2.  Chronic High Fat Diet Consumption Impairs Metabolic Health of Male Mice.

Authors:  Eugenia Morselli; Alfredo Criollo; Carlos Rodriguez-Navas; Deborah J Clegg
Journal:  Inflamm Cell Signal       Date:  2014

3.  Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sites.

Authors:  Margarita M Ivanova; Kristen H Luken; Amber S Zimmer; Felicia L Lenzo; Ryan J Smith; Maia W Arteel; Tara J Kollenberg; Kathleen A Mattingly; Carolyn M Klinge
Journal:  FASEB J       Date:  2011-01-13       Impact factor: 5.191

4.  Disorder-to-order transition underlies the structural basis for the assembly of a transcriptionally active PGC-1α/ERRγ complex.

Authors:  Srikripa Devarakonda; Kushol Gupta; Michael J Chalmers; John F Hunt; Patrick R Griffin; Gregory D Van Duyne; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-02       Impact factor: 11.205

Review 5.  A sexually dimorphic hypothalamic response to chronic high-fat diet consumption.

Authors:  E Morselli; A P Frank; B F Palmer; C Rodriguez-Navas; A Criollo; D J Clegg
Journal:  Int J Obes (Lond)       Date:  2015-06-15       Impact factor: 5.095

6.  Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.

Authors:  Eugenia Morselli; Esther Fuente-Martin; Brian Finan; Min Kim; Aaron Frank; Cristina Garcia-Caceres; Carlos Rodriguez Navas; Ruth Gordillo; Michael Neinast; Sarada P Kalainayakan; Dan L Li; Yuanqing Gao; Chun-Xia Yi; Lisa Hahner; Biff F Palmer; Matthias H Tschöp; Deborah J Clegg
Journal:  Cell Rep       Date:  2014-10-16       Impact factor: 9.423

7.  Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

Authors:  Masaki Shiota; Akira Yokomizo; Yasuhiro Tada; Junichi Inokuchi; Katsunori Tatsugami; Kentaro Kuroiwa; Takeshi Uchiumi; Naohiro Fujimoto; Narihito Seki; Seiji Naito
Journal:  Mol Endocrinol       Date:  2009-11-02

8.  Multiple binding modes between HNF4alpha and the LXXLL motifs of PGC-1alpha lead to full activation.

Authors:  Geun Bae Rha; Guangteng Wu; Steven E Shoelson; Young-In Chi
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

9.  Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress.

Authors:  Jinhwan Kim; Tae Gyu Choi; Yan Ding; Yeonghwan Kim; Kwon Soo Ha; Kyung Ho Lee; Insug Kang; Joohun Ha; Randal J Kaufman; Jinhwa Lee; Wonchae Choe; Sung Soo Kim
Journal:  J Cell Sci       Date:  2008-11-01       Impact factor: 5.285

10.  Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors.

Authors:  M Hauglid Flågeng; L L Haugan Moi; J M Dixon; J Geisler; E A Lien; W R Miller; P E Lønning; G Mellgren
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.